ALEXANDER GADDI: Open Payments
NPI 1750008116 · RAMSEY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$167 in 9 payments from 8 companies in 2025. Trend: 2023 $54 · 2024 $133 · 2025 $167
Food & beverage: $167
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Boston Scientific Corporation | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Kerendia, WATCHMAN Access System, EVENITY, MOUNJARO, OTEZLA, GARDASIL 9, Veozah, FARXIGA.
Industry payments across NJ — which companies pay providers there.
